Epidemiological study on juvenile systemic sclerosis in France
Uvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort
University Hospital, Strasbourg, France · NCT06019234
This study is collecting information about juvenile systemic sclerosis in children to better understand how it affects them and improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 1 Year to 17 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06019234 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather and analyze data on juvenile systemic sclerosis, a rare autoimmune condition affecting children. By compiling experiences from various reference centers in France, the study seeks to improve understanding of the clinical presentation, management, and follow-up of this condition. The research focuses on the incidence, complications, and treatment outcomes in pediatric patients diagnosed between 2012 and 2022. The goal is to enhance therapeutic strategies and reduce mortality associated with this disease.
Who should consider this trial
Good fit: Ideal candidates for this study are minors under 18 years old diagnosed with systemic sclerosis between January 1, 2012, and June 30, 2022.
Not a fit: Patients who do not have a diagnosis of systemic sclerosis or who are over 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and outcomes for children with juvenile systemic sclerosis.
How similar studies have performed: While studies on adult systemic sclerosis have shown success, this specific focus on juvenile cases is novel and under-researched.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Minor subject (\<18 years old) * Diagnosis of systemic sclerosis between 01/01/2012 and 30/06/2022. * Subject (and/or his parental authority) who has not expressed, after being informed, his opposition to the reuse of his data for the purposes of this research. Exclusion criteria: - Subject (or his parents) having expressed his (their) opposition to participating in the study
Where this trial is running
Strasbourg
- Service de Pédiatrie 1 - CHU de Strasbourg - France — Strasbourg, France (RECRUITING)
Study contacts
- Study coordinator: Ariane ZALOSZYC, MD
- Email: ariane.zaloszyc@chru-strasbourg.fr
- Phone: 33 3 88 12 77 42
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Juvenile Systemic Sclerosis, Systemic Sclerosis, Immunosuppressive treatments